Markels John

CIK 00018034243 companiesSAN CARLOS, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001803424

Recent Transactions

23 trades

Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2026-07-16+23,029→ 23,029 total
Award
Arcturus Therapeutics Holdings Inc.$ARCT
Stock option (right to buy)
2026-06-05+15,000→ 15,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Stock Option (Right to Buy)
2025-06-12+50,000→ 50,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2025-06-12+25,000→ 96,384 total
Award
Arcturus Therapeutics Holdings Inc.$ARCT
Stock option (right to buy)
2025-06-09+15,000→ 15,000 total
Exercise/Conversion
Arcturus Therapeutics Holdings Inc.$ARCT
Common Stock
2024-06-14+3,131→ 3,131 total
Award
Arcturus Therapeutics Holdings Inc.$ARCT
Stock option (right to buy)
2024-06-14+15,000→ 15,000 total
Exercise/Conversion
Arcturus Therapeutics Holdings Inc.$ARCT
Deferred Stock Units
2024-06-14−3,131→ 0 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2024-06-04+25,000→ 71,384 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Stock Option (Right to Buy)
2024-06-04+50,000→ 50,000 total
Award
Arcturus Therapeutics Holdings Inc.$ARCT
Stock option (right to buy)
2023-08-01+11,869→ 11,869 total
Award
Arcturus Therapeutics Holdings Inc.$ARCT
Deferred Stock Units
2023-08-01+3,131→ 3,131 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2023-06-01+13,900→ 46,384 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Stock Option (Right to Buy)
2023-06-01+27,750→ 27,750 total
Award
Arcturus Therapeutics Holdings Inc.$ARCT
Stock option (right to buy)
2022-12-08+20,000→ 20,000 total
Award
Arcturus Therapeutics Holdings Inc.$ARCT
Stock option (right to buy)
2022-12-08+6,986→ 6,986 total
Purchase
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2022-06-03$3.69/sh+6,784→ 32,484 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2022-02-25+12,500→ 25,700 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Stock Option (Right to Buy)
2022-02-25+25,000→ 25,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Stock Option (Right to Buy)
2021-02-25+16,400→ 16,400 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2021-02-25+8,200→ 13,200 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2020-02-11+5,000→ 5,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Stock Option (Right to Buy)
2020-02-11+30,000→ 30,000 total

Companies

Recent Filings

Address

C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, SUITE 300

SAN CARLOS, CA, 94070

View on SEC.gov